+44 1803 865913
By: John Parrington(Editor), Kevin Coward(Editor)
Gives an overview of how emerging genomic and proteomic technologies are making significant contributions to global drug discovery programs, and in particular the key role that comparative genomics and proteomics play within this strategy. Each chapter is written by respected authorities, with hands-on experience, from both academic and pharmaceutical backgrounds.
1. Comparative Genomics and Drug Discovery in Trypanosomatids
2. The Practical Implications of Comparative Kinetoplastid Genomics
3. The Relevance of Host Genes in Malaria
4. Nicotinic Acetylcholine Receptors as Drug/Chemical Targets, Contributions from Comparative Genomics, Forward and Reverse Genetics
5. Discovery of Novel Sodium Channel Inhibitors - A Gene Family-Based Approach
6. 'Omics' in Translational Medicine : Are They Lost in Translation?
7. Drug-Target Discovery In Silico: Using the Web to Identify Novel Molecular Targets for Drug Action
There are currently no reviews for this book. Be the first to review this book!
Your orders support book donation projects
This really is first rate customer service.
Search and browse over 110,000 wildlife and science products
Multi-currency. Secure worldwide shipping
Wildlife, science and conservation since 1985